Inventor · disambiguated record
Daniel Tavares
Also filed as: TAVARES DANIEL · TAVARES DANIEL J
54 granted patents·26 pending applications·948 citations·filing 2002–2024
99Inventor score
Top patents by PatentIndex Score
80 records- 0198US7557189B2Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2003·Granted Jul 7, 2009·109 cites·44 claims
- 0298US7342110B2Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2006·Granted Mar 11, 2008·82 cites·10 claims
- 0397US10752683B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2019·Granted Aug 25, 2020·13 cites·31 claims
- 0497US9670279B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·26 cites·118 claims
- 0597US9359442B2Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2014·Granted Jun 7, 2016·29 cites·10 claims
- 0697US9133275B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2013·Granted Sep 15, 2015·45 cites·44 claims
- 0796US9670280B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·19 cites·74 claims
- 0896US9670278B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·18 cites·104 claims
- 0996US9657100B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted May 23, 2017·16 cites·40 claims
- 1096US9598490B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Mar 21, 2017·18 cites·40 claims
- 1196US8557966B2Folate receptor 1 antibodies and immunoconjugates and uses thereofAB OLGA·Filed 2011·Granted Oct 15, 2013·89 cites·20 claims
- 1296US8119787B2Molecular tools for manufacturing anti-CD33 antibodies and fragmentsHOFFEE MARY G·Filed 2009·Granted Feb 21, 2012·21 cites·20 claims
- 1395US8765917B2CD37-binding molecules and immunoconjugates thereofDECKERT JUTTA·Filed 2011·Granted Jul 1, 2014·31 cites·26 claims
- 1495US8337855B2Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameHOFFEE MARY G·Filed 2011·Granted Dec 25, 2012·26 cites·17 claims
- 1594US10875925B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2020·Granted Dec 29, 2020·3 cites·12 claims
- 1694US10077313B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2016·Granted Sep 18, 2018·12 cites·28 claims
- 1794US10017578B2Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodiesIMMUNOGEN INC·Filed 2017·Granted Jul 10, 2018·12 cites·29 claims
- 1894US9346887B2CD37-binding molecules and immunoconjugates thereofIMMUNOGEN INC·Filed 2013·Granted May 24, 2016·12 cites·41 claims
- 1994US9200073B2Diagnostic assays and kits for detection of folate receptor 1IMMUNOGEN INC·Filed 2013·Granted Dec 1, 2015·23 cites·15 claims
- 2094US8153765B2Anti-CD38 antibodies for the treatment of cancerPARK PETER U·Filed 2007·Granted Apr 10, 2012·164 cites·30 claims
- 2194US7538195B2Anti-IGF-I receptor antibodyIMMUNOGEN INC·Filed 2002·Granted May 26, 2009·57 cites·29 claims
- 2293US11332535B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2020·Granted May 17, 2022·2 cites·14 claims
- 2393US11198736B2Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibodyIMMUNOGEN INC·Filed 2019·Granted Dec 14, 2021·5 cites·28 claims
- 2493US10919969B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2017·Granted Feb 16, 2021·4 cites·4 claims
- 2593US10613093B2Diagnostic assays and kits for detection of folate receptor 1IMMUNOGEN INC·Filed 2018·Granted Apr 7, 2020·4 cites·17 claims
- 2693US10301385B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2017·Granted May 28, 2019·8 cites·28 claims
- 2793US9637547B2Monoclonal antibodies for detection of folate receptor 1IMMUNOGEN INC·Filed 2014·Granted May 2, 2017·15 cites·36 claims
- 2892US11932701B2Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugateIMMUNOGEN INC·Filed 2021·Granted Mar 19, 2024·1 cites·19 claims
- 2992US9702881B2Diagnostic assays and kits for detection of folate receptor 1IMMUNOGEN INC·Filed 2015·Granted Jul 11, 2017·15 cites·27 claims
- 3092US7834155B2CA6 antigen-specific cytotoxic conjugate and methods of using the sameIMMUNOGEN INC·Filed 2005·Granted Nov 16, 2010·13 cites·21 claims
- 3190US10202460B2CD37-binding molecules and immunoconjugates thereofDEBIOPHARM INT SA·Filed 2016·Granted Feb 12, 2019·7 cites·22 claims
- 3290US10180432B2Diagnostic assays and kits for detection of folate receptor 1IMMUNOGEN INC·Filed 2017·Granted Jan 15, 2019·6 cites·17 claims
- 3389US11466095B2CD37-binding molecules and immunoconjugates thereofDEBIOPHARM INT SA·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
- 3489US2024132585A1Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 3588US10544230B2Methods of using antibodies to detect folate receptor 1 (FOLR1)IMMUNOGEN INC·Filed 2018·Granted Jan 28, 2020·4 cites·25 claims
- 3688US10442865B2Methods of use of anti-CD123 antibodies and antigen-binding fragments thereofIMMUNOGEN INC·Filed 2018·Granted Oct 15, 2019·4 cites·16 claims
- 3788US8747851B2Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the sameIMMUNOGEN INC·Filed 2012·Granted Jun 10, 2014·4 cites·7 claims
- 3888US2024360240A1Antibodies and assays for detection of folate receptor 1IMMUNOGEN INC·Filed 2024·Application pending·0 cites
- 3987US2025216392A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI AVENTIS US LLC·Filed 2024·Application pending·0 cites
- 4083US8268617B2Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructsSINGH RAJEEVA·Filed 2009·Granted Sep 18, 2012·2 cites·12 claims
- 4182US8460667B2EPHA2 receptor antagonist antibodiesBLANC VERONIQUE·Filed 2007·Granted Jun 11, 2013·8 cites·65 claims
- 4281US11897961B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2022·Granted Feb 13, 2024·0 cites·11 claims
- 4380US8668910B2Antibodies that specifically bind to the EphA2 receptorBOUCHARD HERVE·Filed 2010·Granted Mar 11, 2014·5 cites·25 claims
- 4479US11104740B2Antibodies and assays for detection of CD37DEBIOPHARM INT SA·Filed 2016·Granted Aug 31, 2021·2 cites·19 claims
- 4579US2023213524A1Diagnostic assays and kits for detection of folate receptor 1IMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 4677USRE47123EEPHA2 receptor antagonist antibodiesSANOFI SA·Filed 2007·Granted Nov 13, 2018·2 cites·72 claims
- 4776US2024400676A1Anti-cd19 antibodies and uses therofMILLENNIUM PHARM INC·Filed 2024·Application pending·0 cites
- 4876US2024190956A1Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 4975US10988531B2Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2015·Granted Apr 27, 2021·1 cites·11 claims
- 5075US9676864B2Antibodies that specifically bind to the EphA2 receptorSANOFI SA·Filed 2014·Granted Jun 13, 2017·2 cites·19 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →